EUVIMEDEUVIMED entdecken
Crossref

Screening of neoplastic Lesions of the Small Bowel Using Capsule Endoscopy in Lynch Syndrome. The iCARE4Lynch Study

A Becq, M Jeay, J Grimaldi, E Cauchin, M Dhooge, A Martin, P Cortegoso Valdivia, F De Castelbajac, L Deutsch, J Egea Valenzuela, L Elli, B González Suárez und 7 weitere

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S38-S39

DOI: 10.1055/s-0046-1820698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von A Becq und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Lynch Syndrome (LS) is an autosomal dominant genetic predisposition responsible for multiple cancers, including the rare small bowel (SB) adenocarcinoma. There is no formal recommendation regarding the need for screening. Since the 2000s, small bowel capsule endoscopy (SBCE) has become the reference method for SB exploration. The diagnostic and therapeutic yield of screening for neoplastic lesions by SBCE is poorly documented. The aim of this study was to evaluate the diagnostic yield of a first (index) screening SBCE in patients with LS.

Methods

We conducted a European multicenter cohort study. Patients carrying a pathogenic variant of a DNA mismatch repair (MMR) gene, who were asymptomatic and screened by SBCE for suspected neoplastic lesions, were included. Data was collected between January 2000 and December 2024. The primary endpoint was the diagnostic yield of an index SBCE, defined as the proportion of patients diagnosed with neoplastic lesions. Secondary endpoints were the diagnostic yield of follow-up SBCE, adverse events, technical performance, age at lesion diagnosis, impact of SBCE on management, and lesion frequency depending on the type of pathogenic variant.

Results

A total of 346 patients were screened in the study, with 21 (6.1%) excluded due to symptoms. A total of 325 patients were included for analysis. The mean age was 51.0 (±11.2) years, and 146 patients (45%) were male. The genetic variants identified were MLH1 (94, 29.2%), MSH2 (144, 44.5%), MSH6 (66, 20.5%), PMS2 (21, 6.5%), and EPCAM (0, 0%). Two hundred and eighteen (63.0%) patients had a personal history of LS-related cancer, and 289 (83.5%) had a first-degree family history of small bowel adenocarcinoma. SBCE was ingested in 324 (99.8%) cases. Small bowel examination was complete in 325 (100%) patients. The bowel cleanliness rate was adequate in 287 (88.2%) of cases. In terms of adverse events, aspiration was noted in 0 (0%) patients, and retention was noted in 2 (0.4%) patients, requiring extraction (endoscopic or surgical) in 1 (0.2%) patient. The diagnostic yield of the index SBCE was 7.1%, identifying a neoplastic lesion in 23 patients, including 4 adenocarcinomas. The mean age at diagnosis of neoplastic lesions was 64 (±11.7) years. Among the 302 patients with a normal SBCE, 111 underwent a second SBCE after a mean interval of 3.8 years (±1.9). The diagnostic yield for the second SBCE was 8.1% (9 patients), none of whom had adenocarcinoma. The mean age at diagnosis of neoplastic lesions was 56 (±9.5) years.

Conclusions

In this European multicenter study including 325 patients with LS, the first small bowel SBCE performed for screening purposes had a diagnostic yield of 7.1%. The diagnostic yield of a second SBCE performed after a 3.8-year interval was 8.1%. The adverse event rate was 0.4%. These results suggest that screening SBCE is warranted or to the least has a definite role, in patients with LS. Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Becq, A., Jeay, M., Grimaldi, J., Cauchin, E., Dhooge, M., Martin, A., Valdivia, P. C., Castelbajac, F. D., Deutsch, L., Valenzuela, J. E., Elli, L., Suárez, B. G., Silva, V. M. D., Pennazio, M., Riccioni, M. E., Dardenne, A., Perrod, G., Saurin, J. C., & Dray, X. (2026). Screening of neoplastic Lesions of the Small Bowel Using Capsule Endoscopy in Lynch Syndrome. The iCARE4Lynch Study. Endoscopy, 58(S 03 S 03), S38-S39. https://doi.org/10.1055/s-0046-1820698

Vancouver

Becq A, Jeay M, Grimaldi J, Cauchin E, Dhooge M, Martin A, et al. Screening of neoplastic Lesions of the Small Bowel Using Capsule Endoscopy in Lynch Syndrome. The iCARE4Lynch Study. Endoscopy. 2026;58(S 03 S 03):S38-S39. doi:10.1055/s-0046-1820698

BibTeX
@article{Becq2026,
  author = {Becq, A and Jeay, M and Grimaldi, J and Cauchin, E and Dhooge, M and Martin, A and Valdivia, P Cortegoso and Castelbajac, F De and Deutsch, L and Valenzuela, J Egea and Elli, L and Suárez, B González and Silva, V Macedo Da and Pennazio, M and Riccioni, M E and Dardenne, A and Perrod, G and Saurin, J C and Dray, X},
  title = {Screening of neoplastic Lesions of the Small Bowel Using Capsule Endoscopy in Lynch Syndrome. The iCARE4Lynch Study},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S38--S39},
  doi = {10.1055/s-0046-1820698}
}
Kostenlos starten →